Biothera, Eagan, MN, has received GRAS designation for its yeast beta glucans. An independent panel of medical and toxicology experts recently determined that Biothera’s WGP 3-6 and BetaRight 3-6 meet the requirements for self-affirmed GRAS status. The panel reviewed extensive scientific data, including safety, toxicology and manufacturing process data. Biothera will provide FDA with notification of the GRAS Panel’s decision.